Neuroimaging abnormalities and seizure recurrence in a prospective cohort study of zambians with human immunodeficiency virus and first seizure.
dc.contributor.affiliation | College of Human Medicine, Michigan State University , East Lansing, MI, USA. | |
dc.contributor.affiliation | Epilepsy Division, Department of Neurology, University of Rochester , NY, USA ; Chikankata Epilepsy Care Team , Mazabuka, Zambia. | |
dc.contributor.affiliation | Clinical Epilepsy Section, United States National Institutes of Health , Bethesda, MD, USA. | |
dc.contributor.affiliation | Greater Lawrence Family Health Center , Lawrence, MA, USA. | |
dc.contributor.affiliation | Centre for Infectious Disease Research in Zambia , Lusaka, Zambia. | |
dc.contributor.affiliation | Division of NeuroVirology, Beth Israel Deaconess Medical Center , Boston, MA, USA. | |
dc.contributor.affiliation | Department of Psychology, University of Zambia , Lusaka, Zambia. | |
dc.contributor.affiliation | Neuroradiology Division Department of Imaging Sciences, University of Rochester , NY, USA. | |
dc.contributor.affiliation | Department of Internal Medicine, University of Zambia , Lusaka, Zambia ; Division of NeuroVirology, Beth Israel Deaconess Medical Center , Boston, MA, USA. | |
dc.contributor.affiliation | CIDRZ | |
dc.contributor.affiliation | Centre for Infectious Disease Research in Zambia (CIDRZ) | |
dc.contributor.author | Potchen MJ | |
dc.contributor.author | Siddiqi OK | |
dc.contributor.author | Elafros MA | |
dc.contributor.author | Koralnik IJ | |
dc.contributor.author | Theodore WH | |
dc.contributor.author | Sikazwe I | |
dc.contributor.author | Kalungwana L | |
dc.contributor.author | Bositis CM | |
dc.contributor.author | Birbeck GL | |
dc.date.accessioned | 2025-05-23T11:42:15Z | |
dc.date.issued | 2014-Oct-23 | |
dc.description.abstract | In HIV-positive individuals with first seizure, we describe neuroimaging findings, detail clinical and demographic risk factors for imaging abnormalities, and evaluate the relationship between imaging abnormalities and seizure recurrence to determine if imaging abnormalities predict recurrent seizures. Among 43 participants (mean 37.4 years, 56% were male), 16 (37%) were on antiretroviral drugs, 32 (79%) had advanced HIV disease, and (28) 66% had multiple seizures and/or status epilepticus at enrollment. Among those with cerebrospinal fluid studies, 14/31 (44%) had opportunistic infections (OIs). During follow-up, 9 (21%) died and 15 (35%) experienced recurrent seizures. Edema was associated with OIs (odds ratio: 8.79; confidence interval: 1.03-236) and subcortical atrophy with poorer scores on the International HIV Dementia Scale) (5.2 vs. 9.3; P=0.002). Imaging abnormalities were not associated with seizure recurrence or death (P>0.05). Seizure recurrence occurred in at least a third and over 20% died during follow-up. Imaging was not predictive of recurrent seizure or death, but imaging abnormalities may offer additional diagnostic insights in terms of OI risk and cognitive impairment. | |
dc.identifier.doi | 10.4081/ni.2014.5547 | |
dc.identifier.uri | https://pubs.cidrz.org/handle/123456789/10641 | |
dc.source | Neurology international | |
dc.title | Neuroimaging abnormalities and seizure recurrence in a prospective cohort study of zambians with human immunodeficiency virus and first seizure. |